ORPHA:664734
EBV susceptibility with hemophagocytic lymphohistiocytosis as a major feature
Synonyms: Epstein-Barr virus susceptibility with hemophagocytic lymphohistiocytosis as a major feature
- Type
- Clinical group
- Group
- Group of disorders
- Status
- active
This term does not characterize a disease but a group of diseases. To learn about the diseases included under this term, you can consult the classifications.
1
Names in Orphadata languages
10 of 12 languages| Lang | Name | Synonyms |
|---|---|---|
| en | EBV susceptibility with hemophagocytic lymphohistiocytosis as a major feature | Epstein-Barr virus susceptibility with hemophagocytic lymphohistiocytosis as a major feature |
| fr | Susceptibilité à l'EBV avec lymphohistiocytose comme manifestation majeure | Susceptibilité au virus Epstein-Barr avec lymphohistiocytose hémophagocytaire comme manifestation majeure · Susceptibilité à l'EBV avec hémagophagocytose lymphohistiocytaire comme manifestation majeure |
| de | EBV-Suszeptibilität mit hämophagozytischer Lymphohistiozytose als Hauptmerkmal | Epstein-Barr-Virus-Suszeptibilität mit hämophagozytischer Lymphohistiozytose als Hauptmerkmal |
| es | Susceptibilidad al EBV con linfohistiocitosis hemofagocítica como característica principal | Susceptibilidad al virus de Epstein-Barr con linfohistiocitosis hemofagocítica como característica principal |
| it | Suscettibilità al virus di Epstein-Barr con linfoistiocitosi emofagocitica come caratteristica principale | Predisposizione al virus di Epstein-Barr con linfoistiocitosi emofagocitica come caratteristica principale · Suscettibilità al virus di Epstein-Barr con linfoistiocitosi emofagocitica come caratteristica principale |
| nl | EBV-susceptibiliteit met hemofagocytaire lymfohistiocytose als hoofdkenmerk | Susceptibiliteit voor Epstein-Barrvirus met hemofagocytaire lymfohistiocytose als hoofdkenmerk |
| pt | Suscetibilidade a EBV com linfohistiocitose hemofagocítica como característica principal | Suscetibilidade a virus Epstein-Barr com linfohistiocitose hemofagocítica como característica principal |
| pl | Podatność za zakażenie EBV z limfohistiocytozą hemofagocytarną jako główną cechą | = en |
| cs | Vnímavost k EBV s hemofagocytární lymfohistiocytózou jako hlavním znakem | = en |
| uk | Сприйнятливість до EBV з гемофагоцитарним лімфогістіоцитозом як основною ознакою | Сприйнятливість до вірусу Епштейна-Барр з гемофагоцитарним лімфогістіоцитозом як основною ознакою |
2
Cross-references
qualifier = Orphanet mapping relation| Source | Code | Qualifier | ICD relation | Validation |
|---|---|---|---|---|
| UMLS | C5925063 | E | validated |
E exact · NTBT this ORPHAcode is narrower than the target · BTNT broader than the target · ND not decided.
3
Classification
Preferential parent (Orphanet linearisation):
Parents in the classifications (1):
- ORPHA:664456Immune dysregulation disease with immunodeficiency associated with EBV susceptibility
rare genetic diseases; rare immunological diseases
4
Genes
0 directOrphanet records no gene directly on this code.
5
Prevalence and incidence
0 recordsNo prevalence record in this release.
6
HPO phenotypes
Orphanet has no HPO annotation for this code in this release.
7
Sources for this card
- Orphanet page: orpha.net/en/disease/detail/664734
- This record as JSON: /data/d/664734.json